These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 16243830)
1. Silencing of human phosphatidylethanolamine-binding protein 4 sensitizes breast cancer cells to tumor necrosis factor-alpha-induced apoptosis and cell growth arrest. Wang X; Li N; Li H; Liu B; Qiu J; Chen T; Cao X Clin Cancer Res; 2005 Oct; 11(20):7545-53. PubMed ID: 16243830 [TBL] [Abstract][Full Text] [Related]
2. A novel human phosphatidylethanolamine-binding protein resists tumor necrosis factor alpha-induced apoptosis by inhibiting mitogen-activated protein kinase pathway activation and phosphatidylethanolamine externalization. Wang X; Li N; Liu B; Sun H; Chen T; Li H; Qiu J; Zhang L; Wan T; Cao X J Biol Chem; 2004 Oct; 279(44):45855-64. PubMed ID: 15302887 [TBL] [Abstract][Full Text] [Related]
3. Anti-apoptotic hPEBP4 silencing promotes TRAIL-induced apoptosis of human ovarian cancer cells by activating ERK and JNK pathways. Li P; Wang X; Li N; Kong H; Guo Z; Liu S; Cao X Int J Mol Med; 2006 Sep; 18(3):505-10. PubMed ID: 16865237 [TBL] [Abstract][Full Text] [Related]
4. Phosphatidylethanolamine-binding protein 4 is associated with breast cancer metastasis through Src-mediated Akt tyrosine phosphorylation. Li H; Huang F; Fan L; Jiang Y; Wang X; Li J; Wang Q; Pan H; Sun J; Cao X; Wang X Oncogene; 2014 Sep; 33(37):4589-98. PubMed ID: 24276246 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab. Jazirehi AR; Vega MI; Chatterjee D; Goodglick L; Bonavida B Cancer Res; 2004 Oct; 64(19):7117-26. PubMed ID: 15466208 [TBL] [Abstract][Full Text] [Related]
6. Human phosphatidylethanolamine-binding protein 4 promotes transactivation of estrogen receptor alpha (ERalpha) in human cancer cells by inhibiting proteasome-dependent ERalpha degradation via association with Src. Liu H; Qiu J; Li N; Chen T; Cao X J Biol Chem; 2010 Jul; 285(29):21934-42. PubMed ID: 20460377 [TBL] [Abstract][Full Text] [Related]
7. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544 [TBL] [Abstract][Full Text] [Related]
8. Potentiation of tumor necrosis factor-alpha-induced tumor cell apoptosis by a small molecule inhibitor for anti-apoptotic protein hPEBP4. Qiu J; Xiao J; Han C; Li N; Shen X; Jiang H; Cao X J Biol Chem; 2010 Apr; 285(16):12241-7. PubMed ID: 20177075 [TBL] [Abstract][Full Text] [Related]
9. hPEBP4 resists TRAIL-induced apoptosis of human prostate cancer cells by activating Akt and deactivating ERK1/2 pathways. Li H; Wang X; Li N; Qiu J; Zhang Y; Cao X J Biol Chem; 2007 Feb; 282(7):4943-4950. PubMed ID: 17178731 [TBL] [Abstract][Full Text] [Related]
10. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells. Yu W; Liao QY; Hantash FM; Sanders BG; Kline K Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656 [TBL] [Abstract][Full Text] [Related]
11. BAG-1 overexpression attenuates luminal apoptosis in MCF-10A mammary epithelial cells through enhanced RAF-1 activation. Anderson LR; Sutherland RL; Butt AJ Oncogene; 2010 Jan; 29(4):527-38. PubMed ID: 19881545 [TBL] [Abstract][Full Text] [Related]
12. Asiatic acid, a triterpene, induces apoptosis and cell cycle arrest through activation of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways in human breast cancer cells. Hsu YL; Kuo PL; Lin LT; Lin CC J Pharmacol Exp Ther; 2005 Apr; 313(1):333-44. PubMed ID: 15626723 [TBL] [Abstract][Full Text] [Related]
13. TNF alpha acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-kappa B-dependent pathways. Rivas MA; Carnevale RP; Proietti CJ; Rosemblit C; Beguelin W; Salatino M; Charreau EH; Frahm I; Sapia S; Brouckaert P; Elizalde PV; Schillaci R Exp Cell Res; 2008 Feb; 314(3):509-29. PubMed ID: 18061162 [TBL] [Abstract][Full Text] [Related]
14. Requirement for Ras/Raf/ERK pathway in naringin-induced G1-cell-cycle arrest via p21WAF1 expression. Kim DI; Lee SJ; Lee SB; Park K; Kim WJ; Moon SK Carcinogenesis; 2008 Sep; 29(9):1701-9. PubMed ID: 18296682 [TBL] [Abstract][Full Text] [Related]
15. Ziyuglycoside II induces cell cycle arrest and apoptosis through activation of ROS/JNK pathway in human breast cancer cells. Zhu X; Wang K; Zhang K; Zhu L; Zhou F Toxicol Lett; 2014 May; 227(1):65-73. PubMed ID: 24680927 [TBL] [Abstract][Full Text] [Related]
16. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells. Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183 [TBL] [Abstract][Full Text] [Related]
17. CD24 enhances DNA damage-induced apoptosis by modulating NF-κB signaling in CD44-expressing breast cancer cells. Ju JH; Jang K; Lee KM; Kim M; Kim J; Yi JY; Noh DY; Shin I Carcinogenesis; 2011 Oct; 32(10):1474-83. PubMed ID: 21798852 [TBL] [Abstract][Full Text] [Related]
18. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells. Yin F; Giuliano AE; Law RE; Van Herle AJ Anticancer Res; 2001; 21(1A):413-20. PubMed ID: 11299771 [TBL] [Abstract][Full Text] [Related]
19. Momordica cochinchinensis Spreng. seed extract suppresses breast cancer growth by inducing cell cycle arrest and apoptosis. Zheng L; Zhang Y; Liu Y; Yang XO; Zhan Y Mol Med Rep; 2015 Oct; 12(4):6300-10. PubMed ID: 26252798 [TBL] [Abstract][Full Text] [Related]
20. Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells. Park H; Lee YJ; Kim TH; Lee J; Yoon S; Choi WS; Myung CS; Kim HS Int J Mol Med; 2008 Nov; 22(5):605-11. PubMed ID: 18949380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]